CEO – Michael Matula, Ph.D., J.D.
Michael has accumulated a diverse business background over the past twenty years. He holds a Ph.D. in Biochemistry and J.D. from The University of Texas and has been a practicing attorney and businessman with experience in real estate development, oil & gas exploration and services, investments, and law. From 2004 to 2009 he was President & CEO of an oilfield services company in Carthage, Texas. For the past 10 years, he has been an active angel investor having invested in over 40 early stage companies and has been an interim CEO for several tech companies.
Scientific Director – Pravin Malla Shrestha, Ph.D.
Pravin is a microbiologist with in-depth knowledge of aerobic/ anaerobic bacteria physiology, cultivation, & strain characterization with extensive experience in optimizing and troubleshooting microbiology, molecular biology, & immunodiagnostics assays.
He has had extensive scientific research experience in academia and industry over the last 15 years. He obtained his Ph.D. in Molecular Ecology, Microbiology & Biogeochemistry from the Max Planck Institute – Philipps University at Marburg, Germany. After which, he completed post-doctoral programs at University of Massachusetts–Amherst and University of California–Berkeley. He worked at Assembly Biosciences in San Francisco, California before joining Paratus Diagnostics.
Engineering Director – Ryan Prince
Ryan oversees the development of technology solutions for diagnostic challenges and has innovated key components for the company’s point-of-care testing platform. With an innate love of complex problem solving, Ryan has been getting his hands dirty with Engineering projects since the age of 12, competing in Robotics competitions at the national level. He enjoys being part of a team and leading innovation on the cutting edge of diagnostics. His prior work experience includes Engineering World Health and MediTrak Life.
He has B.S. in Biomedical Engineering with a minor in Electrical Engineering from Purdue University.
Clinical Lab Director – Christine Bulot, Ph.D.
Christine earned her masters degree in genetics from the University of New Orleans and Ph.D. in biomedical sciences from Tulane University School of Medicine. She has over 15 years’ successful laboratory experience including clinical, research and academic labs as well as FDA and CDC collaboration. She is certified by the American Board of Bioanalysis as a High Complexity Clinical Laboratory Director and by the College of American Pathologists as a Laboratory Inspector Team Lead. She earned the Excellence in Leadership award for her work at the Texas Department of State Health Services laboratory and is concurrently Associate Professor of Biology at Austin Community College.
Board of Directors
No photo but he looks similar to this.
Dr. Rick McKinney
Rick has been an active participant in a number of businesses that include founding member of Arbor House assisted livings, multiple home healthcare agencies, an accountable care organization, private allied health schools, Selexys Pharmaceuticals, board member and owner of Oklahoma State Bank.
He holds a MS in Chemistry from Texas A&M and a Doctor of Osteopathic Medicine from University of North Texas Health Science Center – Texas College Osteopathic Medicine. He completed a Medical Oncology Fellowship at the University of Texas M. D. Anderson Hospital and retired from practicing oncology in 2008.
He and his wife Deborah live in Austin, Texas and have two adult children, one living in Austin and one in Santa Barbara, California.
Dr. Phil Jones
Phil Jones is a recently retired urologist from Norman, Oklahoma with diverse business interests including medical, biotech, energy, ranching, and real estate ventures. He co-founded Norman Urology Associates and has served as president of the Norman Physician Hospital Organization and the Oklahoma State Urologic Association. He also directed the Strategic Planning Committee as a Board Member of the Norman Regional Hospital Trust Authority.
Dr. Jones served as the lead angel and board member of Selexys Pharmaceuticals, recently acquired by Novartis Pharmaceuticals, which developed a promising treatment for sickle cell anemia. He currently serves on the board of Tetherex Pharmaceuticals which is focused upon new treatments for thrombotic and inflammatory diseases.
Dr. Jones is skillfully advised in all phases of business and life by his attorney-wife Cathleen and is protected from his longhorn cattle by his ranch partners and sons, Colin of Norman, Oklahoma, and Logan of Austin, Texas.
Rob Donnelly is an investor and entrepreneur with 18 years of investment management, private equity, real estate, and corporate board experience. His former roles include principal investing, portfolio management and executive management in emerging companies.
In 1999, he was a founding principal of Genesis Park, a Houston-based venture capital, private equity, and real estate fund that invested across a diverse range of industries and structures. Mr. Donnelly’s experience in venture includes life sciences, material sciences, and software; while his private equity interests cover buy out, turn-around and value-add opportunities. In 2014, he formed the Texas Regional Investment Center and currently works with EB5 immigrant investors in securing US Residency by investing in quality real estate projects.
Mr. Donnelly earned a B.S. in Biomedical Science from Texas A&M University and an M.B.A. in Finance from Southern Methodist University.
Dr. Michael Matula
Michael has accumulated a diverse business background over the past twenty years. He has been a practicing attorney and businessman with experience in real estate development, oil & gas exploration and services, investments, law, and Biotech. For the past 10 years, he has been an active angel investor having invested in over 40 early stage companies. During that time, he has been CEO for several tech companies.